Skip to the page

Data / Drug companies / Westminster Pharmaceuticals, LLC

Westminster Pharmaceuticals, LLC: 175 products in the FDA NDC directory, labeler code 69367

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Westminster Pharmaceuticals, LLC (labeler code 69367) lists 175 products in the FDA National Drug Code Directory, covering 62 finished drugs by generic name. By type: 164 prescription drugs, 11 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on August 10, 2026.

The request: Watch Westminster Pharmaceuticals, LLC (FDA labeler code 69367): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
69367
Products in commercial distribution
175
Packages
280
Finished drugs by generic name
62
Prescription products
164
Over the counter products
11
Controlled substance products
Schedule III 2, Schedule IV 20, Schedule V 22
Flagged as original packager
157 of 157 products that carry the flag
Started marketing in the last 12 months
34
Products with a marketing end date set
8
Earliest marketing start
April 1, 2016
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)12370.3%
Other unapproved drugs4123.4%
Over the counter monograph drugs116.3%

Products by type

TypeProductsShare
Prescription drugs16493.7%
Over the counter drugs116.3%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Tablet4425.1%
Tablet, film coated3620.6%
Capsule2715.4%
Tablet, coated1810.3%
Tablet, extended release116.3%
Tablet, film coated, extended release95.1%
Liquid74%
Cream52.9%
Syrup31.7%
Paste21.1%
Gel21.1%
Suppository21.1%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Triprolidine hydrochloride69367-450SyrupOver the counter monograph drugsAugust 10, 2026
Methenamine Mandelate69367-437Tablet, film coatedOther unapproved drugsMarch 19, 2026
Methenamine Mandelate69367-436Tablet, film coatedOther unapproved drugsMarch 19, 2026
Ibuprofen69367-449Tablet, film coatedGeneric drugs (ANDA)March 9, 2026
Ibuprofen69367-448Tablet, film coatedGeneric drugs (ANDA)March 9, 2026
Ibuprofen69367-447Tablet, film coatedGeneric drugs (ANDA)March 9, 2026
Phenobarbital69367-445TabletOther unapproved drugsMarch 6, 2026
Phenobarbital69367-444TabletOther unapproved drugsMarch 6, 2026
Phenobarbital69367-443TabletOther unapproved drugsMarch 6, 2026
Phenobarbital69367-442TabletOther unapproved drugsMarch 6, 2026
Phenobarbital69367-441TabletOther unapproved drugsMarch 6, 2026
Phenobarbital69367-440TabletOther unapproved drugsMarch 6, 2026
Phenobarbital69367-439TabletOther unapproved drugsMarch 6, 2026
Phenobarbital69367-438TabletOther unapproved drugsMarch 6, 2026
Paliperidone69367-435Tablet, extended releaseGeneric drugs (ANDA)December 9, 2025
Paliperidone69367-434Tablet, extended releaseGeneric drugs (ANDA)December 9, 2025
Paliperidone69367-433Tablet, extended releaseGeneric drugs (ANDA)December 9, 2025
Paliperidone69367-432Tablet, extended releaseGeneric drugs (ANDA)December 9, 2025
Carisoprodol69367-420TabletGeneric drugs (ANDA)November 25, 2025
Carisoprodol69367-419TabletGeneric drugs (ANDA)November 25, 2025
Theophylline (Anhydrous)69367-415Tablet, extended releaseGeneric drugs (ANDA)November 25, 2025
Theophylline (Anhydrous)69367-414Tablet, extended releaseGeneric drugs (ANDA)November 25, 2025
Pindolol69367-422TabletGeneric drugs (ANDA)November 18, 2025
Pindolol69367-421TabletGeneric drugs (ANDA)November 18, 2025
Venlafaxine Hydrochloride69367-418Tablet, extended releaseGeneric drugs (ANDA)November 18, 2025

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.